Respire_final-01
  • CORPORATE
    • Company Overview
    • Company Management
    • Board of Directors
    • Scientific Team Leaders
    • Social Media Guidelines
  • NEUROTRANSMISSION
  • PHARMACEUTICAL CANNABINOIDS
    • Background
    • Pharmaceutical Cannabinoids
    • Obstructive Sleep Apnea
    • Dronabinol for the Treatment of Obstructive Sleep Apnea
    • Regulatory Process
  • NEUROMODULATORS
    • Ampakines
      • Lead Compounds
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Spinal Cord Injury (SCI)
      • Autism Spectrum Disorder (ASD)
    • GABAkines
      • Background
      • Epilepsy
      • Pain
  • PRODUCT PIPELINE
  • INVESTORS
    • Investor Contact
    • SEC Reports
    • News
    • FAQs
    • Presentations
  • CONTACT

RespireRx Pharmaceuticals Inc. (formerly Cortex Pharmaceuticals, Inc.) is a biopharmaceutical company developing innovative and revolutionary treatments to combat disorders caused by disruption of neuronal signaling.

In the News

4/22/2021 – RespireRx Pharmaceuticals Inc. Provides Update on Its Development Programs

April 22, 2021j3ff1

2/8/2021 – Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI

February 8, 2021j3ff1

2/8/2021 – RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split

February 8, 2021j3ff1
All News
feature1

Neuromodulators

Read More
feature3

Pharmaceutical Cannabinoids

Read More

 

©2016 RespireRx Phamaceuticals Inc. All Rights Reserved.